Aurobindo Pharma Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:	524804	NSE Symbol:	AUROPHARMA	P/E :	37.68
ISIN Demat:	INE406A01037	Div & Yield %:	0	EPS :	29.81
Book Value:	350.46	Market Cap (Rs. Cr.):	65,809.69	Face Value :	1

Date	Headline
24-Jun-25	CuraTeQ Biologics receives UK MHRA approval for biosimilar Dyrupeg™
16-Jun-25	Aurobindo Pharma incorporates WoS in USA
17-May-25	Aurobindo Pharma announces board meeting date
26-Apr-25	CuraTeQ Biologics s.r.o. receives positive opinion for biosimilar Dazublys® from EMA
11-Apr-25	USFDA inspects Aurobindo Pharma's Raleigh Plant in North Carolina
09-Apr-25	CuraTeQ Biologics completes Phase 1 study of denosumab biosimilar, BP16
21-Mar-25	Aurobindo Pharma update on preferential issue by Curateq Biologics
19-Mar-25	Apitoria Pharma's Unit-V completes USFDA inspection
05-Mar-25	Auro Vaccines terminates license agreement with Hilleman Laboratories Singapore
28-Feb-25	Aurobindo Pharma acquires 80% stake in Tergene Biotech

Company Snapshot